Publications by authors named "Bob Lin"

Claim this Profile
H
HI-CeFSpot: High-throughput Immune Cell FluoroSpot assay.
Yogita Jethmalani, Matthew S Sutton, Robin Carroll, Rachel Kazmierski, Kwang Low, Cecilia S Lindestam Arlehamn, Bob C Lin

Methods· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial.
Alex Luedtke, Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Lindsay N Carpp, Flora Castellino, Bob C Lin, James G Kublin, Linda-Gail Bekker

iScience· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood Samples.
Dean Follmann, Lauren Dang, Eric Chu, Jonathan Fintzi, Holly Janes, Bob Lin, Lindsey Baden

J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, Jeffrey A Cohen, Zachary S Wallace, Bob C Lin

JCI Insight· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization Breadth.
Camila T França, Sergei Pletnev, Bharat Madan, Phinikoula S Katsamba, Krisha McKee, Bob C Lin

Vaccines (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronidase-enhanced subcutaneous delivery of bNAbs: a phase 1 randomized controlled clinical trial in HIV-uninfected women.
Sharana Mahomed, Farzana Osman, Martin Beliveau, Roberto Heredia-Ortiz, Kevin Carlton, Bob C Lin

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody.
Sharana Mahomed, Nonhlanhla N Mkhize, Leonid A Serebryannyy, Tandile Hermanus, Prudence Kgagudi, Bob C Lin

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.
Nathaniel Erdmann, Wilton B Williams, Stephen R Walsh, Derek W Cain, Matthew Clark, Bob C Lin, Lindsey R Baden

medRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults.
Richard L Wu, Katherine V Houser, Martin R Gaudinski, Alicia T Widge, Seemal F Awan, Xiaolin Wang, Galina V Yamshchikov, Bob C Lin

Lancet HIV· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.
Kenta Matsuda, Mitra Harrison, Eleanor Wettstein, Jessica Pederson, Alyssa A Pullano, Ryan N Lin, Bob Lin

Nat Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection.
Lela Kardava, James Lim, Clarisa M Buckner, Felipe Lopes de Assis, Xiaozhen Zhang, Bob C Lin

Cell Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, Jeffrey A Cohen, Zachary S Wallace, Bob C Lin

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection.
Myra Happe, Rebecca M Lynch, Carl J Fichtenbaum, Sonya L Heath, Susan L Koletar, Frida Belinky, Bob C Lin

JCI Insight· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial.
Srilatha Edupuganti, Christopher B Hurt, Kathryn E Stephenson, Yunda Huang, Carmen A Paez, Zonglin He, Bob C Lin

Lancet HIV· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage.
Rosemarie D Mason, Baoshan Zhang, Nicholas C Morano, Chen-Hsiang Shen, Krisha McKee, Bob C Lin

Cell Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques.
Hua Wang, Cheng Cheng, James L Dal Santo, Chen-Hsiang Shen, Tatsiana Bylund, Colin A Howe, Bob C Lin, Ivelin S Georgiev

Cell· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies.
Evan M Cale, Chen-Hsiang Shen, Adam S Olia, Nathan A Radakovich, Reda Rawi, Bob C Lin

Cell Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
Lindsay N Carpp, Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Flora Castellino, Bob C Lin, Linda-Gail Bekker, James G Kublin

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.
Matthew Gagne, Barbara J Flynn, Shayne F Andrew, Josue Marquez, Dillon R Flebbe, Bob C Lin, Baoling Ying, Lingshu Wang

Nat Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1.
Jianliang Xu, Tongqing Zhou, Krisha McKee, Baoshan Zhang, Cuiping Liu, Bob C Lin

Adv Sci (Weinh)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
Kassoum Kayentao, Aissata Ongoiba, Anne C Preston, Sara A Healy, Zonghui Hu, Bob C Lin

N Engl J Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Bob C Lin

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
Seemal F Awan, Amarendra Pegu, Larisa Strom, Cristina A Carter, Cynthia S Hendel, Bob C Lin

JCI Insight· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.
Madhu Prabhakaran, Flavio Matassoli, David Leggat, Abigayle Hoover, Abhinaya Srikanth, Bob C Lin

Sci Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site.
Bailey B Banach, Sergei Pletnev, Adam S Olia, Kai Xu, Baoshan Zhang, Bob C Lin

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis